Archive for Junio, 2009

New Animal Study Of Rexahns Serdaxin™ Shows Drugs Promise To Treat Anxiety And Depression With Minimal Side Effects

Posted by admin on Junio 17th, 2009 under depression Tags: ,  •  No Comments

Rexahn Pharmaceuticals, Inc. (NYSE Amex RNN), announced the results of a wideranging animal study offering more evidence that Serdaxin™ may be an effective therapeutic for the treatment of anxiety disorders in humans. Serdaxin is Rexahns leading anxiety and depression drug candidate, and is currently in Phase II clinical trials.
The research tested Clavulanic acid, the [...]

Mental Health America Honors Outstanding Advocates At Its Centennial Conference

Posted by admin on Junio 16th, 2009 under mental health Tags: ,  •  No Comments

Mental Health America honored two extraordinary mental health advocates on Saturday during the final day of its Centennial Conference.
Leading mental health advocate Dr. Jerry Grammer for his tireless efforts to improve conditions for mental health consumers, during its 2009 Centennial Conference in Washington, D.C.
Dr. Jerry Grammar, a clinical psychologist and board member of [...]

L.A. County, Calif., Offers Home Delivery Of Chlamydia, Gonorrhea Test Kits

Posted by admin on Junio 15th, 2009 under sexual health Tags: ,  •  No Comments

Los Angeles County health officials on Wednesday announced a program that will offer young women home delivery of chlamydia and gonorrhea testing kits and send them a text message when the results are available, the AP/San Francisco Chronicle reports. The $450,000 program aims to curb the rapid spread of sexually transmitted infections in the county [...]

Aberrant ERG Expression Cooperates With Loss Of PTEN To Promote Cancer Progression In The Prostate

Posted by admin on Junio 15th, 2009 under urology nephrology Tags: ,  •  No Comments

UroToday.com Two papers in the May 5, 2009 edition of Nature Genetics link ERG chromosomal gene translocations with loss of PTEN in the early stages of prostate cancer (CaP) progression. Both are reviewed in Urotoday.
In this report, Dr. Brett Carver and colleagues studied TMPRSS2ERG genetic rearrangement, which are reported in up to [...]

New Studies Presented At European Society Of Anaesthesia Further Validate Masimo PVI(TM) For Noninvasive And Continuous Fluid Monitoring

Posted by admin on Junio 13th, 2009 under conferences Tags: , ,  •  No Comments

Masimo (Nasdaq MASI), the inventor of Pulse COOximetry(TM) and MeasureThrough Motion and LowPerfusion pulse oximetry, announced that three new independent studies demonstrating the clinical accuracy and utility of Masimo PVI as a noninvasive and continuous measure of patient fluid status and responsiveness were presented this week at the European Society of Anaesthesiology (ESA) Annual [...]

Opposition To Abortion Rights Declining Among Black Voters, Opinion Pieces States

Posted by admin on Junio 12th, 2009 under abortion Tags: ,  •  No Comments

“In recent years, conservative political strategists have painted African Americans as being more opposed to abortion than the white population,” but experts believe that there actually “is a declining black support for conservative social policies like abortion,” Tracie Powell, a former congressional fellow with the American Political Science Association, writes in a CQ Politics opinion [...]

Arizona ADAP Cuts Number Of Medications Covered Under Program

Posted by admin on Junio 12th, 2009 under sexual health Tags: , ,  •  No Comments

The Arizona AIDS Drug Assistance Program (ADAP) has reduced the number of medications it will cover antiretrovirals and drugs that treat opportunistic infections will not be affected, the Arizona Daily Star reports. The program relies heavily on federal funding. Judy Norton, chief of the states Office of HIV, STD and Hepatitis C Services, [...]

InteKrin Therapeutics Announces INT131 Phase 2a Results At The 2009 American Diabetes Association Annual Meeting

Posted by admin on Junio 11th, 2009 under diabetes Tags: , ,  •  No Comments

InteKrin Therapeutics Inc presented Phase 2a clinical study results at the American Diabetes Association annual meeting in New Orleans demonstrating that once a day oral treatment with INT131 provides antidiabetic efficacy consistent with maximal dose thiazolidinedione (TZD) therapy but with less hematocrit reduction and weight gain.
The 4 week double blind placebo controlled [...]

BPA May Cause Heart Disease In Women, Said Scientists Studying Rats

Posted by admin on Junio 11th, 2009 under womens health Tags: ,  •  No Comments

A team of scientists in the US suggested that bisphenol A (BPA) may harm the heart, particularly in women, because of what they discovered in tests on female rats and mice. BPA is a chemical used in the manufacture of polycarbonate, a hard clear plastic used to make food containers, among other things.
The findings [...]

Opinion Pieces Discuss Violence Against Abortion Providers, Future Of Profession

Posted by admin on Junio 10th, 2009 under abortion Tags: , ,  •  No Comments

The Los Angeles Times and the Washington Post recently published opinion pieces responding to the shooting death of Kansas abortion provider George Tiller. Summaries appear below.~ Suzanne Poppema, Los Angeles Times “We must turn [Tillers] terrifying end into the beginning of a new era when doctors can save lives without risking their own,” Poppema, a [...]